AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-178121401/fda-approves-generic-versions.html" title="Facts and information about FDA approves generic versions of popular osteoporosis drug.(IN THE NEWS)">FDA approves generic versions of popular osteoporosis drug.(IN THE NEWS)</a>
Close
Set up an RSS feed that alerts you when new articles from Health News are available.
Frequently asked questions about RSS feeds
FDA approves generic versions of popular osteoporosis drug.(IN THE NEWS)
[ILLUSTRATION OMITTED]
The U.S. Food and Drug Administration (FDA) approved the first generic versions of the popular osteoporosis drug Fosamax (alendronate) on February 6, 2008. Fosamax, made by Merck & Co., is among the top 100 most frequently dispensed drugs in the united states. Currently Fosamax costs $80 to $85 per month. Although generic drugs are chemically identical to their branded counterparts, they are sold at substantial discounts. Teva Pharmaceuticals USA will manufacture the generic ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- FDA approves generic versions of Fosamax.
- News wire article from: UPI NewsTrack February 7, 2008 700+ words
WASHINGTON, Feb. 7 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of the osteoporosis drug Fosamax (alendronate sodium tablets). Teva Pharmaceuticals USA of North Wales, Pa., was approved...
- Amgen near breakthrough on osteoporosis drug.
- Newspaper article from: Denver Post (Denver, CO) Johnson, Kimberly S. August 10, 2005 700+ words
...testing of what could be a breakthrough osteoporosis drug that would be produced in Boulder...in San Francisco. By 2006, the osteoporosis drug market will reach $11.5 billion...prescribed Fosamax, the leading osteoporosis drug. (She is not a part of Amgen...
- Amgen Osteoporosis Drug Denosumab Lowers Spinal Fracture Risk By 68 Pct. In...
- News wire article from: The America's Intelligence Wire September 17, 2008 700+ words
...AMBIKA AHUJA FinancialWire-17 September 2008-Amgen Osteoporosis Drug Denosumab Lowers Spinal Fracture Risk By 68 Pct. In Study...NASDAQ: AMGN) has released data showing that its osteoporosis drug candidate denosumab dramatically cut the risk of spinal...
- New Osteoporosis Drug Appears to Build Bone.
- News wire article from: Indianapolis Star (Indianapolis, IN) May 10, 2001 700+ words
...experimental drug Forteo appears to do something better than any osteoporosis drug on the market: actually build bone, even in frail, elderly...human protein that regulates calcium, expects to put the osteoporosis drug on the market this year. The U.S. Food and Drug Administration...
- NovaDx discovers osteoporosis drug opportunities; drug & diagnostic research...
- Press release article from: Business Wire April 22, 1997 700+ words
...is pleased to announce the discovery of new targets for osteoporosis drug development. These proteins were identified by the Company...pharmaceutical partner to assist in the development of these new osteoporosis drug opportunities. -0- NOTE: The Vancouver Stock Exchange...
- Dual-Action Osteoporosis Drug Candidate Targeting Critical Disease Gene...
- Press release article from: Business Wire October 16, 2000 700+ words
...initial results of in vivo studies on its small-molecule osteoporosis drug, demonstrating not only inhibition of bone breakdown but...of new bone formation. Development of a dual-action osteoporosis drug that affects both stages of the normal process of bone...
- Court rules Richter osteoporosis drug does not infringe Merck's.
- News wire article from: Europe Intelligence Wire January 18, 2006 700+ words
...Regional Court of Appeals ruled on Tuesday that a generic osteoporosis drug produced by Hungary's Richter does not infringe on US...generic drugs, also introduced an alendronate sodium-based osteoporosis drug in Hungary at the same time as Richter. Turnover from...
- New cancer weapon: Osteoporosis drug cuts breast cancer risk with fewer side...
- Newspaper article from: Newsday (Melville, NY) April 18, 2006 700+ words
...chances of developing the disease are high. Raloxifene, an osteoporosis drug sold as Evista, reduced the risk of invasive breast cancer...product of Eli Lily Inc., raloxifene is approved only as an osteoporosis drug. Three of the study's participants, who accompanied...
- Richter stands by legality of osteoporosis drug.
- News wire article from: Europe Intelligence Wire June 7, 2005 700+ words
...Drugmaker Richter Gedeon announced on Tuesday that an osteoporosis drug it makes with the active ingredient alendronate is in no...an announcement by rival Merck, which also produces an osteoporosis drug with the active ingredient alendronate, saying the Budapest...
- FDA Extends Review Of Pfizers Osteoporosis Drug Fablyn.
- News wire article from: The America's Intelligence Wire October 21, 2008 700+ words
...FinancialWire-21 October 2008-FDA Extends Review Of Pfizers Osteoporosis Drug Fablyn (C)2008 Investrend Communications, Inc. October...Administration has extended by three months its review of a proposed osteoporosis drug, Fablyn, from Pfizer Inc. (NYSE: PFE). Pfizer developed...
Source: HighBeam Research, FDA approves generic versions of popular osteoporosis drug.(IN THE...